Lactococcus lactis LL-23 is a strain of the lactic acid bacterium Lactococcus lactis. This microbe ferments dairy products like cheese and buttermilk. Some research on L. Lactis probiotics examines whether the bacteria can survive stomach acid and produce helpful enzymes. Evidence for the LL-23 strain specifically is scarce.
Early animal studies looked at whether L. Lactis supports gut barrier function and immune signaling. But no well-controlled human trials exist for LL-23 as a probiotic. Major probiotic databases do not widely recognize this strain. Most claims rely on general Lactococcus traits, not data from LL-23 itself.
Capsule or powder forms are taken with food to reduce stomach acid exposure. There is no established dose.
Since this strain is not well-validated, its safety, effectiveness, and interactions remain unknown. People with weakened immune systems or serious health conditions should be cautious with any uncharacterized bacterial supplement.